Efficacy and Safety of Dapagliflozin as Monotherapy for Type 2 Diabetes Mellitus in Japanese Patients

被引：0
|
作者：
Kaku, Kohei
Inoue, Satoshi
Matsuoka, Osamu
Kiyosue, Arihiro
Azuma, Haruna
Hayashi, Nobuya
Tokudome, Takuto
Langkilde, Anna Maria
Parikh, Shamik
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1014-P
引用
收藏
页码：A260 / A260
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and inadequate glycaemic control on glimepiride monotherapy
    Strojek, K.
    Hruba, A.
    Elze, M.
    Langkilde, A.
    Parikh, S.
    [J]. DIABETOLOGIA, 2010, 53
  • [2] Efficacy and Safety of Dapagliflozin Monotherapy in Japanese Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise
    Kaku, Kohei
    Kiyosue, Arihiro
    Inoue, Satoshi
    Ueda, Naohiko
    Tokudome, Takuto
    Yang, Jisin
    Langkilde, Anna Maria
    [J]. DIABETES, 2013, 62 : A303 - A303
  • [3] Efficacy and Safety of Long-Term Administration of Dapagliflozin for Japanese Patients with Type 2 Diabetes Mellitus
    Yamazaki, Masahiro
    Sakai, Ryosuke
    Okamura, Takuro
    Fukui, Michiaki
    [J]. DIABETES, 2018, 67
  • [4] Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes
    Nonaka, Kenji
    Kakikawa, Taro
    Sato, Asako
    Okuyama, Kotoba
    Fujimoto, Go
    Kato, Naoki
    Suzuki, Hideyo
    Hirayama, Yukio
    Ahmed, Tuli
    Davies, Michael J.
    Stein, Peter P.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (02) : 291 - 298
  • [5] Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus A meta-analysis of randomized controlled trials
    Feng, Miao
    Lv, Haihong
    Xu, Xia
    Wang, Jue
    Lyu, Wenyi
    Fu, Songbo
    [J]. MEDICINE, 2019, 98 (30)
  • [6] Efficacy and Safety of Dapagliflozin for Type 2 Diabetes Mellitus Patients With a History of Cardiovascular Disease
    Leiter, Lawrence A.
    Cefalu, William T.
    Debruin, Tjerk W.
    Gausenilsson, Ingrid
    Sugg, Jennifer
    Parikh, Shamik J.
    [J]. DIABETES, 2012, 61 : A287 - A287
  • [7] Comparison of safety and efficacy of dapagliflozin and empagliflozin in type 2 diabetes mellitus patients in India
    Varshney, Amit
    Rawat, Ramakant
    [J]. REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2023, 69 (08):
  • [8] Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and concomitant heart failure
    Kosiborod, M.
    Gause-Nilsson, I.
    Sonesson, C.
    Johnsson, E.
    [J]. DIABETOLOGIA, 2015, 58 : S368 - S368
  • [9] Safety and efficacy of empagliflozin monotherapy in a 52-week study in Japanese patients with type 2 diabetes mellitus
    Woerle, H. J.
    Kadowaki, T.
    Haneda, M.
    Inagaki, N.
    Taniguchi, A.
    Sakamoto, M.
    Koiwai, K.
    Rattunde, H.
    Broedl, U. C.
    [J]. DIABETOLOGIA, 2013, 56 : S371 - S372
  • [10] Safety and Efficacy of Empagliflozin Monotherapy in a 52-Week Study in Japanese Patients with Type 2 Diabetes Mellitus
    Kadowaki, Takashi
    Haneda, Masakazu
    Inagaki, Nobuya
    Taniguchi, Atsushi
    Koiwai, Kazuki
    Rattunde, Henning
    Broedl, Uli C.
    Woerle, Hans-Juergen
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
12345